The round was led by Seventure Partners and by Zaffre Investments, the investment fund of Blue Cross Blue Shield of Massachusetts. Jason Robart, chief strategy officer of Blue Cross Blue Shield of Massachusetts and president and CEO of Zaffre Investments, joined Zipongo’s board of directors.
The company intends to use funding to expand its nutrition platform beyond wellness to use food as first-line therapy in treating chronic disease.
Launched in 2014 by CEO Jason Langheier, MD, MPH, Zipongo provides a Food Benefits Management (FBM) platform that delivers sustained engagement to allow people to assess and improve their nutrition via tools including Health (Digital Dietitian), Cooking (recipes, meal planning, grocery delivery, and discounts) and Restaurants (menus, restaurant ordering, and workplace cafes).
The company is now expanding its technology platform to allow health plans and providers to use food to treat chronic disease, through a new solution called FoodScripts. FoodScripts adds specific modules to the Zipongo platform that address conditions such as hypertension, diabetes, obesity and more through prescriptive, personalized, evidence-based nutrition programs. The company plans to roll out an early version of FoodScripts to pilot customers in the early spring.
FinSMEs
22/01/2018